financetom
Business
financetom
/
Business
/
Masimo smartwatches infringe Apple design patents, US jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Masimo smartwatches infringe Apple design patents, US jury says
Nov 3, 2024 12:04 PM

Oct 25 (Reuters) - Apple ( AAPL ) convinced a federal

jury on Friday that health monitoring tech company Masimo's ( MASI )

smartwatches infringe two of its design patents.

The jury, in Delaware, agreed with Apple ( AAPL ) that Masimo's ( MASI ) W1

and Freedom watches and chargers willfully violated Apple's ( AAPL )

patent rights in smartwatch designs, awarding the tech giant

$250 in damages. Apple's ( AAPL ) attorneys told the court the "ultimate

purpose" of its lawsuit was to win an injunction against sales

of Masimo's ( MASI ) smartwatches after an infringement ruling.

The jury also determined that Masimo's ( MASI ) watches did not

infringe Apple ( AAPL ) patents covering smartwatch inventions that the

tech giant had accused Masimo ( MASI ) of copying.

Masimo ( MASI ) said in a statement that the company appreciated the

jury's verdict "in favor of Masimo ( MASI ) and against Apple ( AAPL ) on nearly

all issues," and that the decision only applied to a

"discontinued module and charger."

"Apple ( AAPL ) primarily sought an injunction against Masimo's ( MASI )

current products, and the jury's verdict is a victory for Masimo ( MASI )

on that issue," Masimo ( MASI ) said.

Apple ( AAPL ) said in a statement that it was "glad the jury's

decision today will protect the innovations we advance on behalf

of our customers."

Irvine, California-based Masimo ( MASI ) accused Apple ( AAPL ) of hiring

away its employees and stealing its pulse oximetry technology

after discussing a potential collaboration. Masimo ( MASI ) convinced the

U.S. International Trade Commission last year to block imports

of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches after the

commission found that their technology for reading blood oxygen

levels infringed Masimo's ( MASI ) patents.

Apple ( AAPL ) has appealed the decision and resumed selling the

watches after removing the technology. The tech giant

countersued Masimo ( MASI ) for patent infringement in 2022, alleging

that Masimo ( MASI ) copied Apple Watch features to use in its

smartwatches.

Apple ( AAPL ) also accused Masimo ( MASI ) of using lawsuits at the ITC

and in California to "make way for Masimo's ( MASI ) own watch." Masimo ( MASI )

said Apple's ( AAPL ) patent lawsuit was "retaliatory" and "an attempt to

avoid the court in which the parties have been litigating their

dispute."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Applied Digital Fiscal Q1 Non-GAAP Loss Widens, Revenue Rises
Applied Digital Fiscal Q1 Non-GAAP Loss Widens, Revenue Rises
Oct 9, 2025
04:34 PM EDT, 10/09/2025 (MT Newswires) -- Applied Digital ( APLD ) reported a fiscal Q1 adjusted net loss late Thursday of $0.03 per diluted share, widening from the loss of $0.01 a year earlier. Four analysts polled by FactSet expected a loss of $0.16. Revenue in the three months ended Aug. 31 rose to $64.2 million from $34.8 million...
USANA Health Sciences Preliminary Q3 Swings to Loss, Net Sales Rise
USANA Health Sciences Preliminary Q3 Swings to Loss, Net Sales Rise
Oct 9, 2025
04:33 PM EDT, 10/09/2025 (MT Newswires) -- USANA Health Sciences ( USNA ) reported fiscal Q3 preliminary adjusted loss late Thursday of $0.15, swinging from earnings of $0.56 a year earlier. Two analysts polled by FactSet expected earnings of $0.56. Preliminary net sales for the quarter ended Sept. 27 were $214 million, up from $200 million a year earlier. Two...
Zivo Bioscience Insider Bought Shares Worth $284,421, According to a Recent SEC Filing
Zivo Bioscience Insider Bought Shares Worth $284,421, According to a Recent SEC Filing
Oct 9, 2025
04:33 PM EDT, 10/09/2025 (MT Newswires) -- Christopher D. Maggiore, 10% Owner, Director, on October 08, 2025, executed a purchase for 23,682 shares in Zivo Bioscience ( ZIVO ) for $284,421. Following the Form 4 filing with the SEC, Maggiore has control over a total of 517,526 common shares of the company, with 517,526 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1101026/000165495425011614/xslF345X05/section16.xml...
BP wins arbitration case against Venture Global over LNG cargoes
BP wins arbitration case against Venture Global over LNG cargoes
Oct 9, 2025
HOUSTON, Oct 9 (Reuters) - BP has won its arbitration case against Venture Global ( VG ) over the U.S. supplier's failure to deliver liquefied natural gas under a long-term contract that was due to start in late 2022, Venture Global ( VG ) said on Thursday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved